Carisma Therapeutics Inc (NASDAQ:CARM)
| 4.00 Delayed Data As of 3:59pm ET |  -0.425 / -9.62%Today’s Change | 2.75 Today|||52-Week Range 13.00 | -67.23% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 990.0K | 30.0M | 425.0K | 0.00 | |
| Depreciation And Amortization | 366.0K | 178.0K | 285.0K | 208.0K | ||
| Operating Expenses | Gross Income | -- | -- | -- | -208.0K | |
| General Expenses | 35.8M | 23.6M | 20.1M | 25.5M | ||
| Research And Development | 26.0M | 12.2M | 12.2M | 13.9M | ||
| Total Operating Expenses | 36.2M | 23.8M | 20.4M | 25.7M | ||
| Non-Operating Expenses | Operating Income | -35.2M | 6.2M | -20.0M | -25.7M | |
| Extraordinary Credit | 3.1M | 1.2M | 5.0K | 0.00 | ||
| Extraordinary Charge | 0.00 | -5.3M | -9.3M | -8.8M | ||
| Interest Expense On Debt | 1.4M | 247.0K | 0.00 | 0.00 | ||
| Other Expenses | 35.0K | 67.0K | 221.0K | 807.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -33.5M | 1.9M | -29.0M | -33.7M | |
| Income Taxes | 0.00 | -5.0K | 0.00 | 0.00 | ||
| Net Income | -33.5M | 1.9M | -29.0M | -33.7M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 19.0M | 21.1M | 26.1M | 61.8M | |
| Shares To Calculate EPS Diluted | 19.0M | 21.7M | 26.1M | 61.8M | ||
| Earnings Per Share | EPS | -$1.76 | $0.09 | -$1.11 | -$0.55 | |
| EPS Diluted | -$1.76 | $0.09 | -$1.11 | -$0.55 | ||
